Sarah Boyce - Director at Contineum Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
CTNM on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Sarah Boyce since 8/15/2023

Holdings reported by Sarah Boyce for Contineum Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (right to buy) 29.5K Jun 24, 2024 Direct Class A Common Stock

Transactions reported by Sarah Boyce for Contineum Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership